UK Markets closed

Kintara Therapeutics, Inc. (KTRA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3435-0.0515 (-13.04%)
As of 01:06PM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2022)Next year (2023)
No. of analysts4354
Avg. Estimate-0.16-0.16-0.59-0.33
Low estimate-0.18-0.18-0.73-0.79
High estimate-0.14-0.14-0.390.64
Year ago EPS-0.22-0.23-1.6-0.59
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2022)Next year (2023)
No. of analysts3343
Avg. EstimateN/AN/AN/A13.09M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A39.28M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/12/202030/03/202129/06/202129/09/2021
Est. EPS-0.14-0.18-0.16-0.14
Actual EPS-0.22-0.23-0.13-0.17
Difference-0.08-0.050.03-0.03
Surprise %-57.10%-27.80%18.80%-21.40%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2022)Next year (2023)
Current estimate-0.16-0.16-0.59-0.33
7 days ago-0.16-0.16-0.59-0.33
30 days ago-0.16-0.16-0.57-0.33
60 days ago-0.16-0.16-0.64-0.66
90 days ago-0.14-0.14-0.58-0.64
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesKTRAIndustrySector(s)S&P 500
Current qtr.27.30%N/AN/AN/A
Next qtr.30.40%N/AN/AN/A
Current year63.10%N/AN/AN/A
Next year44.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A